ѧÊõÌÃÊ×Ò³ | ÎÄÏ×ÇóÖúÂÛÎÄ·¶ÎÄ | ÂÛÎÄÌâÄ¿ | ²Î¿¼ÎÄÏ× | ¿ªÌⱨ¸æ | ÂÛÎĸñʽ | ÕªÒªÌá¸Ù | ÂÛÎÄÖÂл | ÂÛÎIJéÖØ | ÂÛÎÄ´ð±ç | ÂÛÎÄ·¢±í | ÆÚ¿¯ÔÓÖ¾ | ÂÛÎÄд×÷ | ÂÛÎÄPPT
ѧÊõÌÃרҵÂÛÎÄѧϰƽ̨Äúµ±Ç°µÄλÖãºÑ§ÊõÌà > ÉúÎïѧÂÛÎÄ > ÉúÎïÖÆÒ©ÂÛÎÄ

ÉúÎïÖÆÒ©¼¼ÊõµÄÓ¦ÓÃÏÖ×´ÓëÕ¹Íû

À´Ô´£º»¯¹¤Éè¼ÆͨѶ ×÷ÕߣºÎIJý¸ý
·¢²¼ÓÚ£º2019-01-16 ¹²2456×Ö

¡¡¡¡Õª    Òª£º¡¡Ëæ×ÅÎÒ¹ú¾­¼ÃˮƽµÄ²»¶ÏÌá¸ßÒÔ¼°¿Æѧ¼¼ÊõµÄ²»¶Ï·¢Õ¹, ÎÒ¹úµÄÖÆÒ©¹¤ÒÕÒѾ­Öð½¥µÄÍêÉÆ¡£ÌرðÊǽøÈë21ÊÀ¼ÍÒÔÀ´, ÉúÎïÖÆÒ©¼¼ÊõÔÚÎÒ¹úÖÆÒ©¹¤ÒÕÖеõ½Á˼«Îª¹ã·ºµÄÓ¦ÓÃ, Ôںܴó³Ì¶ÈÉÏ´Ù½øÁËÎÒ¹úÖÆÒ©ÐÐÒµµÄ½øÒ»²½·¢Õ¹¡£»ùÓÚ´Ë, Ê×ÏÈ̽ÌÖÁËÖÆÒ©¹¤ÒÕÖÐÉúÎïÖÆÒ©¼¼ÊõµÄÓ¦ÓÃÏÖ×´, Ëæºó¾ÍÆ䷢չǰ¾°Ìá³öÁ˽¨Òé, Ï£Íû¿ÉÒÔ¶ÔÎÒ¹úÉúÎïÖÆÒ©¼¼ÊõÔÚÖÆÒ©¹¤ÒÕÖеÄÓ¦ÓÃÆðµ½Ò»¶¨µÄ½è¼øÒâÒåºÍ´Ù½ø×÷Óá£

¡¡¡¡¹Ø¼ü´Ê£º¡¡ÉúÎïÖÆÒ©¼¼Êõ; ÖÆÒ©¹¤ÒÕ; Ó¦ÓÃÏÖ×´; ·¢Õ¹Ç°¾°;

¡¡¡¡Abstract£º¡¡With the continuous improvement of China's economic level and the continuous development of science and technology, China's pharmaceutical technology has gradually improved.Especially since the beginning of the 21 st century, biopharmaceutical technology has been widely used in China's pharmaceutical technology, which has greatly promoted the further development of China's pharmaceutical industry.Based on this, this paper first discusses the application status of biopharmaceutical technology in pharmaceutical technology, and then puts forward some views on its development prospects.It is hoped that through the research and analysis of this paper, the application of biopharmaceutical technology in pharmaceutical technology in China can be played.Certain reference and promotion.

¡¡¡¡Keyword£º¡¡biopharmaceutical technology; pharmaceutical technology; application status; development prospect;

¡¡¡¡´ÓÄ¿Ç°À´Ëµ, ÎÒ¹úµÄÉúÎïÖÆÒ©¼¼ÊõµÄÓ¦ÓÃÒѾ­È¡µÃÁ˳õ²½µÄ³ÉЧ, ¹ã´óµÄÏû·ÑÕßÒѾ­¿ÉÒÔÆÕ±é½ÓÊܲ¢Ê¹ÓÃÒ»¶¨µÄÉúÎïÖÆÒ©¼¼ÊõÉú²ú¶øÀ´µÄÒ©Æ·, ÔÚ¼ÓÉϹú¼ÒµÄ´óÁ¦Ö§³ÖºÍÒýµ¼, ÉúÎïÖÆÒ©¼¼Êõ±ØÈ»»á³ÉΪÎÒ¹úÖÆÒ©¹¤ÒÕÖÐÊ®·ÖÖØÒªµÄ¹Ø¼ü¼¼ÊõÖ®Ò»[1]¡£µ«ÊÇÄ¿Ç°ÎÒ¹úµÄÉúÎïÖÆÒ©¼¼ÊõÔÚ²»¶Ï·¢Õ¹µÄ¹ý³ÌÕÅÈԾɴæÔÚ×ÅһϵÁеÄÎÊÌâ, ÈçרҵÈ˲ŶÌȱ¡¢¾­·Ñ²»×ãµÈ, Ò²ÑÏÖØ×è°­ÁËÆä½øÒ»²½µÄ·¢Õ¹, Óɴ˿ɼû, ÎÒ¹úÉúÎïÖÆÒ©¼¼ÊõµÄ·¢Õ¹»¹´æÔÚ×ÅÏ൱´óµÄ¿Õ¼ä[2]¡£

¡¡¡¡1 ÉúÎïÖÆÒ©¼¼ÊõÔÚÖÆÒ©¹¤ÒÕÖеÄÓ¦ÓÃÏÖ×´

¡¡¡¡1.1 ¿¹Ö×ÁöÒ©Îï

¡¡¡¡ÉúÎïÖÆÒ©¼¼Êõ´ÓÆäµ®Éú³õʼ, Ö÷ÒªÊÇÓÃÓÚÖ×ÁöµÄÖÎÁÆÓëÔ¤·Àµ±ÖÐ, ·¢Õ¹µ½ÏÖÔÚÖ×Áö¶ÔÈ˵ÄÉíÌ彡¿µ¹¹³ÉÁ˼«´óµÄÍþв, ¶øͨ¹ýÉúÎïÖÆÒ©¼¼Êõ¿ÉÒÔÒÔÔ¤·ÀºÍ»¯ÁƵķ½Ê½¶ÔÖ×ÁöµÄ·¢Õ¹½øÐÐÒ»¶¨µÄ¿ØÖÆ¡£

¡¡¡¡1.2 ÉúÎïø´ß»¯¼¼Êõ

¡¡¡¡ÉúÎïÖÆÒ©¼¼ÊõÉú²ú¶øÀ´µÄÒ©ÎïËäÈ»Ôںܴó³Ì¶ÈÉÏΪÈËÃñȺÖÚµÄÉíÌ彡¿µÌṩÁËÒ»¶¨µÄ±£ÕÏ, µ«ÊÇÆäÔÚÉú²ú»òÖÆ×÷Ò©ÎïµÄ¹ý³ÌÖÐҲʹµÃһЩ²»ÈÝÒ×·Ö½âµÄÓк¦ÎïÖʵIJúÉú, ÔÙ¼ÓÉÏÆäÓëÉú²ú·ÏË®²ôÔÓÔÚÒ»Æð, ´¦ÀíÆðÀ´·Ç³£À§ÄÑ, Óɴ˵®ÉúÁËÉúÎïø´ß»¯¼¼Êõ, ÕâÏî¼¼Êõ¿ÉÒÔÔںܴó³Ì¶ÈÉÏ»º½âÖÆÒ©ÖвúÉúµÄÎÛȾ·ÏÎïºÍ·ÏË®¡£¶ÔÓÚÖÆÒ©²úÉúµÄÄÑÒÔ·Ö½âºÍ´¦ÀíµÄÎÛȾÎï, ÉúÎïø¿ÉÒÔ¶ÔÆä½øÐдó·ù¶ÈµÄ·Ö½âºÍ¾»»¯, ʹÏà¹Ø·ÏÎï¼°ÎÛË®µÄ´¦Àí¸ü¼ÓµÄ¿ì½Ý, Ó¦ÓüÛÖµ¼«¸ß¡£

ÉúÎïÖÆÒ©¼¼ÊõµÄÓ¦ÓÃÏÖ×´ÓëÕ¹Íû

¡¡¡¡ÓëÆäËû¼¼ÊõÏà±È, ÉúÎïø´ß»¯¼¼ÊõÓµÓиüΪǿÁ¦µÄÎÛË®´¦Àí¹¦Ð§, Õë¶ÔÔÚÖÆÒ©¹ý³ÌÖвúÉúµÄ´óÁ¿·ÏË®, ÉúÎïø´ß»¯¼¼Êõ¿ÉÒÔ×î´ó³Ì¶ÈµØʵÏÖºÍÍê³ÉÆäÖеÄÎÛȾÎïÍÑÉ«¡¢È¥Î¶ÒÔ¼°·Ö½â;³ý´ËÖ®Íâ, ÕâÏî¼¼ÊõËùÐèºÄ·ÑµÄ³É±¾Ò²ÊǷdz£µÍµÄ, ¾­¼ÃÊÊÓÃ, ¶øÇÒ¼ò±ãÒ×ѧ¡£

¡¡¡¡1.3 Î÷Ò©ÖÆ×÷·½Ãæ

¡¡¡¡Ïà¹ØѧÕßµÄÑо¿±íÃ÷, ¶ÔÓÚÈËÌåÀ´Ëµ, ÖÐÒ©Ëù²úÉúµÄΣº¦½ÏС, µ«ÊÇ·¢Éú×÷ÓõÄʱ¼ä½ÏΪÂþ³¤;¶øÎ÷Ò©ËäÈ»¸±×÷ÓÃÏà¶Ô½Ï¸ß, µ«ÊÇ·¢»Ó¹¦Ð§Ïà¶Ô½Ï¿ì¡£µ«ÊÇËæ×ÅÏÖ´ú¿Æѧ¼¼ÊõµÄ²»¶Ï·¢Õ¹ÒÔ¼°ÉúÎïÖÆÒ©¼¼ÊõµÄ²»¶ÏÍêÉÆ, ʹµÃÎ÷Ò©µÄ¸±×÷ÓÃÒÔ¼°¶Ô²¡È˵ÄΣº¦Ö𽥵ĽµµÍ, ʹµÃÎ÷Ò©Ö𽥵ر»½ÓÊÜ¡£

¡¡¡¡1.4 ϸ°û¹¤³Ì

¡¡¡¡ÔÚ´«Í³µÄÖÆÒ©¹¤ÒյĹý³ÌÖÐ, Ö²ÎïÓÉÓÚÆäÖÐÐÔÇÒκÍ, ¶ÔÈËÌå²úÉúµÄΣº¦Ïà¶Ô½ÏС, ³ÉΪÁËʹÓÃ×îΪÆÕ±éÇҹ㷺µÄÖÆÒ©Ô­ÁÏ¡£µ«ÊÇËæ×ÅÉç»áµÄ²»¶Ï·¢Õ¹ºÍ½ø²½, ÈËÃǶÔÓÚÒ©ÎïµÄÐèÇóÁ¿Öð½¥µÄÔö¼Ó, ½öͨ¹ýÔÚ´ó×ÔÈ»¿ª²É×ÔÈ»Éú³¤µÄÖ²ÎïÊÇÎÞ·¨Âú×ãÆäÐèÇóµÄ, Òò´Ëϸ°û¹¤³Ì¼¼Êõµ®ÉúÁË¡£ÉúÎïÖÆÒ©¼¼Êõͨ¹ýϸ°û¹¤³ÌµÄ·½Ê½Ò»¶¨ÊýÁ¿µÄ²É¼¯ËùÐèµÄÖ²Îïϸ°û, Ëæºó½øÐдóÁ¿µÄÈ˹¤·±Ö³, ¼«´óµØÂú×ãÁËÈÕÒæÔö³¤µÄÖÆÒ©Ô­ÁÏÐèÇó¡£

¡¡¡¡1.5 »ùÒò¹¤³Ì

¡¡¡¡ÈËÌåÊÇÒ»¸öÊ®·Ö¸´ÔÓµÄÉúÃüÌå, ÌåÄÚijÖÖÒòËصı仯¾ÍÊ®·ÖÓпÉÄܵ¼ÖÂÈËÌåÊܵ½¼²²¡µÄÍþв, ÀýÈçÌÇÄò²¡¾ÍÊÇÒòΪÈËÌåÌåÄÚÒȵºËØ·ÖÃÚ²»×ã»òÕßÊÇÒȵºËØ×÷ÓÃÕÏ°­ÒýÆðµÄ, Õë¶ÔÕâÖÖ¼²²¡µÄÖÎÁÆ¿ÉÒÔ²ÉÓûùÒò¹¤³Ì¼¼ÊõÔÚÖÆÒ©¹¤ÒÕÖеÄÓ¦ÓÃ, ÔÚijÖÖ¶¯ÎïÉíÉÏÌáÈ¡µ½ËùÐèµÄÒȵºËØ, Ëæºó½«Æä½øÐÐÌåÍâµÄºÏ³É, ·ÅÖõ½Î¢ÉúÎïµÄϸ°ûµ±ÖÐ, ¾Í¿ÉÒÔ´óÁ¿²úÉúÈËÌåËùÐèµÄÒȵºËØ¡£

¡¡¡¡2 ÉúÎïÖÆÒ©¼¼ÊõµÄ·¢Õ¹Ç°¾°

¡¡¡¡2.1 ÉúÎïÖÆÒ©¼¼ÊõµÄ·¢Õ¹ÃæÁÙµÄÌôÕ½

¡¡¡¡´ÓijÖ̶ֳÈÀ´Ëµ, ÉúÎïÖÆÒ©ÐÐÒµÔںܴó³Ì¶ÈÉÏÓ°Ïìµ½ÁËÈËÃñȺÖÚµÄÉíÌ彡¿µ, ÕâÒ²¶ÔÉúÎïÖÆÒ©¼¼ÊõµÄ½øÒ»²½·¢Õ¹Ìá³öÁ˸ü¸ßµÄÒªÇó¡£Ä¿Ç°À´Ëµ, ÎÒ¹úµÄÉúÎïÖÆÒ©¼¼Êõ´ó¶à¶¼Êǽè¼øºÍ²ÉÓùúÍâÏȽøµÄ¼¼ÊõºÍÉ豸, ÍêÈ«Óɹú¼Ò¶ÀÁ¢Ñо¿ºÍ¿ª·¢µÄ¼¼ÊõºÍÉ豸Ï൱ÉÙ, ȱ·¦Ò»¶¨µÄ×ÔÖ÷´´ÐÂÄÜÁ¦, Ôںܴó³Ì¶ÈÉÏ×è°­ÁËÎÒ¹úÉúÎïÖÆÒ©¼¼ÊõµÄ·¢Õ¹¡£

¡¡¡¡2.2 ÉúÎïÖÆÒ©²úÒµµÄ·¢Õ¹Ç÷ÊÆ

¡¡¡¡Ëæ×ÅÎÒ¹ú¿Æѧ¼¼ÊõµÄ²»¶Ï·¢Õ¹ÒÔ¼°¾­¼Ãˮƽ²»¶ÏÌá¸ß¶ø´øÀ´µÄ³ä×ãµÄµÄ×ʽðÖ§³Å, ʹµÃÉúÎïÖÆÒ©¼¼ÊõÒѾ­Éæ¼°µ½ÁË·Ö×ÓµÄÁìÓò¡£Óë´Ëͬʱ, ÎÒ¹úÔÚÈËÌåÒÅ´«Ñ§ÒÔ¼°Ò»ÏµÁм²²¡·¢Éú»úÀíµÄÑо¿Ò²ÒѾ­È¡µÃÁËÒ»¶¨µÄ³É¼¨, ²»½öÔںܴó³Ì¶ÈÉÏΪÉúÎïÖÆÒ©¼¼ÊõµÄ·¢Õ¹µì¶¨ÁËÒ»¶¨µÄ»ù´¡, ͬʱҲΪÉúÎïÖÆÒ©¼¼ÊõµÄ·¢Õ¹Ö¸Ã÷ÁË·½ÏòºÍÄ¿±ê¡£

¡¡¡¡ÔÚδÀ´µÄÉúÎïÖÆÒ©¼¼ÊõµÄ·¢Õ¹¹ý³ÌÖÐ, Æä±Ø½«ÓëÈËÌåÉú³¤·¢ÓýÒÔ¼°Éú´æµÈ·½ÃæÓлúµÄ½áºÏÆðÀ´;¶øÏà¹Ø¹¤×÷ÕߵŤ×÷ÖØÐÄÒ²»áÖð½¥µØÇãбµ½ÈçºÎÌá¸ßÒ©Æ·µÄ³É¹¦ÂÊ¡¢½µµÍÒ©Æ·µÄ³É±¾ÒÔ¼°Ìá¸ßÒ©ÎïµÄʹÓ÷¶Î§µÈ·½Ãæ¡£

¡¡¡¡3 ½áÊøÓï

¡¡¡¡×ÛÉÏËùÊö, ÉúÎïÖÆÒ©¼¼ÊõÔںܴó³Ì¶ÈÉÏÓ°Ïìµ½ÁËÈËÃñȺÖÚµÄÉíÌ彡¿µÒÔ¼°ÆäÉú»îµÄÖÊÁ¿ºÍˮƽ¡£Òò´ËÕâ¾ÍÒªÇóÎÒ¹úÕþ¸®¼°ÆäÏà¹ØµÄ²¿ÃűØÐëÒªÒýÆðÉúÎïÖÆÒ©¼¼Êõ·½ÃæµÄÖØÊÓ, ¼Ó´óÖ§³ÖµÄÁ¦¶È, À©´ó²ÆÕþ×ʽðÖ§³Å, ×¢ÖØÉúÎïÖÆҩרҵÈ˲ŵÄÅàÑøÁ¦¶È, ΪÉúÎïÖÆÒ©¼¼ÊõµÄ·¢Õ¹ÒÔ¼°³É¹¦Ò©ÎïµÄÎÊÊÀµì¶¨¼áʵµÄ»ù´¡¡£

¡¡¡¡²Î¿¼ÎÄÏ×£º

¡¡¡¡[1] Áõ½¨·æ, ËïÃç.ÖÆÒ©¹¤ÒÕÖÐÉúÎïÖÆÒ©¼¼ÊõµÄÓ¦Ó÷ÖÎö[J].¿Æ½Ìµ¼¿¯-µç×Ó°æ (ÉÏÑ®) , 2018, (05) :252.
¡¡¡¡[2] ÖÜ·æ, κÆäÑô.ÂÛÉúÎïÖÆÒ©¼¼ÊõÔÚÖÆÒ©¹¤ÒÕÖеÄÓ¦ÓÃ[J].Òûʳ±£½¡, 2018, (24) :285-286.

×÷Õßµ¥Î»£ºº£ÄϺ£Á¦ÖÆÒ©ÓÐÏÞ¹«Ë¾
Ô­Îijö´¦£ºÎIJý¸ý.ÉúÎïÖÆÒ©¼¼ÊõÔÚÖÆÒ©¹¤ÒÕÖеÄÓ¦Óü°·¢Õ¹Ç°¾°[J].»¯¹¤Éè¼ÆͨѶ,2018,44(11):197+199.
  • ±¨¾¯Æ½Ì¨
  • ÍøÂç¼à²ì
  • ±¸°¸ÐÅÏ¢
  • ¾Ù±¨ÖÐÐÄ
  • ´«²¥ÎÄÃ÷
  • ³ÏÐÅÍøÕ¾